Epidemilogical trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer's disease, diabetes mellitus, and non-alcoholic steatohepatitis.
about
Is neurodegenerative disease a long-latency response to early-life genotoxin exposure?Therapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseThe cycad genotoxin MAM modulates brain cellular pathways involved in neurodegenerative disease and cancer in a DNA damage-linked mannerNitrate-nitrite-nitrosamines exposure and the risk of type 1 diabetes: A review of current dataBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseNitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's diseaseNitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment.A New Automated Method and Sample Data Flow for Analysis of Volatile Nitrosamines in Human UrineEarly limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration.Occupational exposure to mineral turpentine and heavy fuels: a possible risk factor for Alzheimer's disease.Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseasesType 3 diabetes is sporadic Alzheimer׳s disease: mini-review.Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's diseaseBrain metabolic dysfunction at the core of Alzheimer's disease.Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewedMeat consumption and its association with C-reactive protein and incident type 2 diabetes: the Rotterdam StudyInsulin resistance and Alzheimer's disease.Early intranasal insulin therapy halts progression of neurodegeneration: progress in Alzheimer's disease therapeutics.Tobacco nitrosamines as culprits in disease: mechanisms reviewedRelationships between diabetes and cognitive impairmentInsulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.Experimental induction of type 2 diabetes in aging-accelerated mice triggered Alzheimer-like pathology and memory deficitsCorrelation and dissociation of electrophysiology and histopathology in the assessment of toxic neuropathy.Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.Tobacco Smoke Exposure Impairs Brain Insulin/IGF Signaling: Potential Co-Factor Role in Neurodegeneration.Processed meat: the real villain?Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration.Long-Term Stability of Volatile Nitrosamines in Human Urine.Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.The 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at 'Type 3 Diabetes', Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential Treatments.
P2860
Q26824755-4AE1D1C2-F06A-4F41-8F88-BEB58F5AA5EEQ27021700-FCD88932-013A-43F5-B502-1C2E9EEB688AQ27335106-BDC27885-999E-49D1-B58F-E6EF7C3F2E72Q28069892-DD329825-82D9-40B2-80A4-8025F2B25560Q28259585-1366EF6E-B9D8-4436-B01C-11AF141B705EQ30479198-A98716DF-F09E-4150-8D15-0C362034C241Q30484122-B28556A2-8420-426A-8BE5-BAF270893F0EQ31053870-C270F189-91DE-44E4-BDD9-1DD6ABBF7135Q33543381-21CDDB73-A352-4E9A-8685-C6F7975F266BQ33860532-EF1524DE-15D1-4977-9451-CBE31FB26213Q34288447-757324B2-FB23-46E6-B904-9C105A5A1CB2Q34432135-1DE319F4-9EFF-4BF0-825B-6E6ED8898EC2Q35997824-1E580A44-80EE-4E50-9B3F-144E75C9D2D8Q35997881-8C5DEB54-B2F4-4150-A192-1202E641C3BDQ35997884-F9A6A9F8-DE53-46D1-BB65-0FF4092745DBQ36047195-EF6370A9-D021-46E6-86B6-FB7737A6043DQ36143429-4560AFFF-79FD-4F13-B014-E827FA907CEEQ36551193-6BB0322D-2AF2-4C7C-A6E0-99F854B842D0Q36906429-3473B8E3-B4ED-4DB3-AAA6-72B8CBA37A44Q37162219-748610A8-42B8-4533-8B27-08244950CB12Q37602608-E22A8B24-BCDF-4EDF-8F60-72D40C5E82FEQ37615991-E5D3679B-47B1-48EF-9DB8-0E54C5F31B07Q37813883-5ED58CBC-773D-41BF-8B20-66392BAE9BC7Q39042377-DF98D273-A76D-4800-AC09-844B0314448DQ40196229-3888D41B-7D79-4F95-97FA-AB86098E529FQ41085976-FC938384-215B-4C43-9C52-68E9481F065EQ41566472-40828CA2-6A69-4B8F-A1A4-45723D423650Q41706493-BB5D84BC-B333-4040-8477-C761283B6A4FQ47122754-329CFB24-F0E3-4713-A977-A19DEEF71379Q55266969-52C41BEA-FD1F-4EA3-A461-7D8F45FDD1CC
P2860
Epidemilogical trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer's disease, diabetes mellitus, and non-alcoholic steatohepatitis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Epidemilogical trends strongly ...... non-alcoholic steatohepatitis.
@ast
Epidemilogical trends strongly ...... non-alcoholic steatohepatitis.
@en
type
label
Epidemilogical trends strongly ...... non-alcoholic steatohepatitis.
@ast
Epidemilogical trends strongly ...... non-alcoholic steatohepatitis.
@en
prefLabel
Epidemilogical trends strongly ...... non-alcoholic steatohepatitis.
@ast
Epidemilogical trends strongly ...... non-alcoholic steatohepatitis.
@en
P2093
P2860
P921
P356
P1476
Epidemilogical trends strongly ...... non-alcoholic steatohepatitis.
@en
P2093
Alexander Neusner
Jennifer Chu
Margot Lawton
Suzanne M de la Monte
P2860
P304
P356
10.3233/JAD-2009-1070
P577
2009-01-01T00:00:00Z